DYN
Dyne Therapeutics Inc.
$21.50
-$2.61(-10.83%)
62
Overall
60
Value
83
Tech
44
Quality
Market Cap
$1.87B
Volume
1.90M
52W Range
$6.36 - $35.68
Target Price
$34.76
EPS Estimates Overview
| Current Quarter | $-0.81 | Next Quarter | $-0.8 |
| Current Year | $-3.58 | Next Year | $-3.39 |
| QoQ Growth | +1.2% | YoY Growth | +5.3% |
| 3Y EPS CAGR | N/A | Target Price | $34.76 |
| Consensus | Buy | Upside | +61.7% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $21.50 | -10.8% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |